China Pharma Holdings, Inc. (CPHI)

Last Closing Price: 0.10 (2024-02-20)

Company Description

CHINA PHARMA HOLDINGS, Inc. develops, manufactures, and markets generic and brand bio-pharmaceutical products in China that treat a wide range of conditions, including infections, hepatitis, cardiovascular and CNS diseases, and other prevailing diseases. Helpson Bio-pharmaceutical Co., Ltd. (Helpson), a specialty pharmaceutical company headquartered in Haikou City, Hainan province in China, is a wholly owned subsidiary of China Pharma Holdings.

Financials, Fundamental Metrics & Ratios
Revenue (Most Recent Fiscal Year) $8.10M
Net Income (Most Recent Fiscal Year) $-3.97M
PE Ratio (Current Year Earnings Estimate) --
PE Ratio (Trailing 12 Months) --
PEG Ratio (Long Term Growth Estimate) --
Price to Sales Ratio (Trailing 12 Months) 0.44
Price to Book Ratio (Most Recent Quarterly Book Value per Share) 0.48
Price to Cash Ratio (Most Recent Annual Cash Flow per Share) --
Pre-Tax Margin (Trailing 12 Months) -39.99%
Net Margin (Trailing 12 Months) -39.99%
Return on Equity (Trailing 12 Months) -64.09%
Return on Assets (Trailing 12 Months) -18.81%
Current Ratio (Most Recent Fiscal Quarter) 0.82
Quick Ratio (Most Recent Fiscal Quarter) 0.29
Debt to Common Equity (Most Recent Fiscal Quarter) 0.23
Inventory Turnover (Trailing 12 Months) 2.21
Book Value per Share (Most Recent Fiscal Quarter) $0.57
Earnings per Share (Most Recent Fiscal Quarter) --
Earnings per Share (Most Recent Fiscal Year) --
Diluted Earnings per Share (Trailing 12 Months) --
Exchange NYSEMKT
Sector Healthcare
Industry Drug Manufacturers - Specialty & Generic
Common Shares Outstanding 32.95M
Free Float 17.79M
Market Capitalization $3.39M
Average Volume (Last 20 Days) 2.47M
Beta (Past 60 Months) 0.97
Percentage Held By Insiders (Latest Annual Proxy Report) 46.00%
Percentage Held By Institutions (Latest 13F Reports) 1.36%
Annual Dividend (Based on Last Quarter) $0.00
Dividend Yield (Based on Last Quarter) 0.00%